Amylin in bone conservation current evidence and hypothetical Considerations
- 1 October 1993
- journal article
- Published by Elsevier in Trends in Endocrinology & Metabolism
- Vol. 4 (8) , 255-259
- https://doi.org/10.1016/1043-2760(93)90095-v
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Selective antagonism of calcitonin-induced osteoclastic quiescence (Q effect) by human calcitonin gene-related peptide-(Val8Phe37)Biochemical and Biophysical Research Communications, 1991
- Co-secretion of amylin and insulin from cultured islet β-cells: Modulation by nutrient secretagogues, islet hormones and hypoglycemic agentsBiochemical and Biophysical Research Communications, 1991
- Amylin activates glycogen phosphorylase in the isolated soleus muscle of the ratFEBS Letters, 1991
- Amylin activates glycogen phosphorylase and inactivates glycogen synthase via a cAMP-independent mechanismBiochemical and Biophysical Research Communications, 1991
- Evidence that the action of calcitonin on rat osteoclasts is mediated by two G proteins acting via separate post-receptor pathwaysJournal of Endocrinology, 1990
- Reduced islet-amyloid polypeptide in insulin-dependent diabetes mellitusThe Lancet, 1990
- AMYLIN AND AMYLIN-AMIDE LACK AN ACUTE EFFECT ON BLOOD GLUCOSE AND INSULINJournal of Endocrinology, 1990
- Establishment of radioimmunoassay for human islet amyloid polypeptide and its tissue content and plasma concentrationBiochemical and Biophysical Research Communications, 1989
- Islet amyloid polypeptide: Identification and chromosomal localization of the human geneFEBS Letters, 1988
- Osteoporosis and calcitonin deficiency.BMJ, 1982